{"id":"exparel","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["SKY0402","Bupivacaine liposome extended-release injectable suspension","bupivacaine liposome injectable suspension","Liposomal bupivacaine","Bupivacaine Liposome"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Exparel","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:14:54.120258+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Exparel","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T02:15:08.558918+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:15:07.431248+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Exparel","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:15:07.999916+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Sodium channel protein type IV alpha subunit blocker","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:15:08.558559+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1098/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:15:08.461861+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"bb5a9e59-0f51-11df-8a39-0800200c9a66","title":"EXPAREL (BUPIVACAINE) INJECTION, SUSPENSION, LIPOSOMAL [PACIRA PHARMACEUTICALS, INC.]"},"ecosystem":[],"_scrapedAt":"2026-03-27T23:29:57.642Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Bupivacaine","title":"Bupivacaine","extract":"Bupivacaine, sold under the brand name Marcaine among others, is a medication used to decrease sensation in a specific small area. In nerve blocks, it is injected around a nerve that supplies the area, or into the spinal canal's epidural space. It is available mixed with a small amount of epinephrine to increase the duration of its action. It typically begins working within 15 minutes and lasts for 2 to 8 hours."},"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:15:10.379889+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06565910","phase":"PHASE4","title":"Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)","status":"RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2024-12-04","conditions":"Femoral Neck Fractures, Femur Head Necrosis, Hip Fractures","enrollment":60},{"nctId":"NCT06235606","phase":"PHASE3","title":"Liposomal Bupivacaine With Standard Bupivacaine Versus Dexmedetomidine With Standard Bupivacaine","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2024-05-08","conditions":"Acute Pain","enrollment":96},{"nctId":"NCT06529432","phase":"PHASE2","title":"A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2026-03-03","conditions":"Local Analgesia Via Nerve Block","enrollment":96},{"nctId":"NCT06559215","phase":"PHASE2","title":"Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population","status":"RECRUITING","sponsor":"Texas Scottish Rite Hospital for Children","startDate":"2025-12-01","conditions":"Medial Patellofemoral Ligament (MPFL) Reconstruction, Sports Injuries in Children, Analgesia","enrollment":100},{"nctId":"NCT05044468","phase":"PHASE2","title":"EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-03-23","conditions":"Malignant Pleural Neoplasm","enrollment":80},{"nctId":"NCT03214510","phase":"PHASE3","title":"Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-04","conditions":"Liver and Intrahepatic Bile Duct Disorder","enrollment":101},{"nctId":"NCT07212114","phase":"PHASE3","title":"Efficacy of EXPAREL vs. Bupivacaine","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-11-17","conditions":"Total Ankle Arthroplasty, Postsurgical Analgesia","enrollment":104},{"nctId":"NCT06077422","phase":"PHASE2, PHASE3","title":"Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain","status":"ENROLLING_BY_INVITATION","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-01-11","conditions":"Pain, Postoperative, Opioid Use, Perioperative Complication","enrollment":150},{"nctId":"NCT07410182","phase":"PHASE4","title":"Bupivacaine Liposome Versus Bupivacaine for Ultrasound-Guided Suprascapular Nerve Combined With Axillary Nerve Block in Analgesia After Arthroscopic Shoulder Surgery","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2026-03-01","conditions":"Arthroscopic Shoulder Surgery, Ultrasound Guided Nerve Block, Bupivacaine","enrollment":60},{"nctId":"NCT04655339","phase":"PHASE2, PHASE3","title":"Laparoscopic Transversus Abdominis Plane (TAP) Block to Reduce Post-operative Opioids","status":"WITHDRAWN","sponsor":"Baylor Research Institute","startDate":"2020-01-24","conditions":"Opioid Use","enrollment":""},{"nctId":"NCT06411795","phase":"PHASE2","title":"Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2023-11-10","conditions":"Duodenal Neoplasm, Pancreatic Neoplasm","enrollment":78},{"nctId":"NCT07246642","phase":"PHASE4","title":"IPP Placement & Intracavernosal Block","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-03","conditions":"Erectile Dysfunction (ED)","enrollment":100},{"nctId":"NCT02591407","phase":"NA","title":"Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal Surgery","status":"COMPLETED","sponsor":"Trinity Health Michigan","startDate":"2016-01-12","conditions":"Colon Cancer, Rectal Cancer, Colonic Diverticulosis","enrollment":200},{"nctId":"NCT05140499","phase":"PHASE4","title":"Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations","status":"TERMINATED","sponsor":"Aurora Quaye","startDate":"2022-08-15","conditions":"Pain, Postoperative, Amputation","enrollment":11},{"nctId":"NCT05720949","phase":"PHASE4","title":"Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2023-01-12","conditions":"ACL, Anterior Cruciate Ligament Injuries","enrollment":192},{"nctId":"NCT07366905","phase":"PHASE2","title":"Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block","status":"NOT_YET_RECRUITING","sponsor":"Hainan Medical College","startDate":"2026-02","conditions":"Patients Eligible for Elective Lower Extremity Femoral Nerve Surgery, Knee Arthroscopic Surgery","enrollment":60},{"nctId":"NCT04189783","phase":"PHASE2","title":"Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients (\"RESQU-SARC\" Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-06-08","conditions":"Retroperitoneal Sarcoma","enrollment":113},{"nctId":"NCT07349810","phase":"PHASE4","title":"Post Operative Infusion Pump Pain Study","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-01-01","conditions":"Post Operative Pain","enrollment":80},{"nctId":"NCT07092566","phase":"PHASE3","title":"R.E.C.K vs Exparel in Robotic Nephrectomy","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-11-14","conditions":"Renal Carcinoma, Nephrectomy / Methods, Pain Management","enrollment":170},{"nctId":"NCT02381353","phase":"PHASE4","title":"Exparel Injection for Postoperative Orbital Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2015-02","conditions":"Pain, Postoperative","enrollment":88},{"nctId":"NCT06165991","phase":"PHASE4","title":"Liposomal and Standard Bupivacaine in Thoracic Paravertebral Block for Post-Thoracoscopic Pain","status":"RECRUITING","sponsor":"Yongtao Sun","startDate":"2024-06-01","conditions":"Thoracic Paravertebral Block, Postoperative Analgesia, Thoracoscopic Lobectomy","enrollment":496},{"nctId":"NCT06587386","phase":"PHASE4","title":"The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function","status":"COMPLETED","sponsor":"Affiliated Hospital of Jiaxing University","startDate":"2025-05-20","conditions":"Motion Sickness","enrollment":55},{"nctId":"NCT06271265","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2024-03-29","conditions":"Postoperative Pain","enrollment":48},{"nctId":"NCT04575688","phase":"PHASE4","title":"Periarticular Injection Versus Popliteal Block","status":"ENROLLING_BY_INVITATION","sponsor":"Campbell Clinic","startDate":"2021-07-13","conditions":"Foot Surgery, Ankle Surgery","enrollment":100},{"nctId":"NCT04126824","phase":"EARLY_PHASE1","title":"Effect of Addition of Steroids on Duration of Analgesia","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-01-06","conditions":"Uterine Fibroids, Adenomyosis","enrollment":28},{"nctId":"NCT05891613","phase":"PHASE4","title":"A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2024-01-24","conditions":"Breast Reduction","enrollment":32},{"nctId":"NCT07279155","phase":"PHASE1","title":"A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-06-09","conditions":"Postoperative Local Analgesia","enrollment":36},{"nctId":"NCT07222748","phase":"PHASE3","title":"A Study of TLC590 for Postsurgical Pain Following Bunionectomy","status":"RECRUITING","sponsor":"TLC Biopharmaceuticals, Inc.","startDate":"2025-11-17","conditions":"Postoperative Pain","enrollment":300},{"nctId":"NCT07254650","phase":"NA","title":"Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-01-01","conditions":"Lung Cancer (Diagnosis)","enrollment":300},{"nctId":"NCT04272086","phase":"PHASE4","title":"Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2020-11-09","conditions":"Fibroid Uterus","enrollment":140},{"nctId":"NCT05868330","phase":"PHASE4","title":"Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties","status":"RECRUITING","sponsor":"Melinda Seering","startDate":"2024-08-19","conditions":"Post Operative Pain, Anesthesia, Nerve Block","enrollment":56},{"nctId":"NCT06574022","phase":"PHASE4","title":"Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2024-09-25","conditions":"Mastectomy; Lymphedema, Breast Cancer","enrollment":100},{"nctId":"NCT07221019","phase":"PHASE4","title":"Single Shot Exparel vs Catheters in Lower Extremity Trauma","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-09-12","conditions":"Fracture Dislocation of Ankle Joint, Fracture Leg, Fracture Femur","enrollment":90},{"nctId":"NCT06179004","phase":"PHASE3","title":"Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-04-10","conditions":"Distal Radius Fractures, Wrist Fractures","enrollment":100},{"nctId":"NCT03743194","phase":"PHASE4","title":"Pectoralis and Serratus Muscle Blocks","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2021-12-14","conditions":"Post Operative Pain Control","enrollment":210},{"nctId":"NCT06617949","phase":"EARLY_PHASE1","title":"Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-01-16","conditions":"Substance Use Disorder (SUD)","enrollment":20},{"nctId":"NCT06471348","phase":"NA","title":"Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-08-15","conditions":"Post Operative Pain, Spinal Fusion","enrollment":128},{"nctId":"NCT06995352","phase":"PHASE4","title":"Liposomal Bupivacaine Versus Continuous Peripheral Nerve Blocks for Analgesia Following Ankle Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, San Diego","startDate":"2025-06-23","conditions":"Moderate-to-severely Painful Ankle Surgery","enrollment":140},{"nctId":"NCT03827291","phase":"PHASE4","title":"QL Block With Exparel in Colectomy","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-10-31","conditions":"Laparotomy, Colectomy","enrollment":35},{"nctId":"NCT06989866","phase":"PHASE3","title":"RCT to Test Regional Anesthesia Effect on Decreased Opiate Use","status":"ENROLLING_BY_INVITATION","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2024-12-01","conditions":"Postoperative Pain","enrollment":50},{"nctId":"NCT06737341","phase":"PHASE4","title":"Bupivacaine Liposomes or Bupivacaine for CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2025-10-08","conditions":"Bupivacaine, Ultrasound-Guided, Analgesia, Postoperative","enrollment":60},{"nctId":"NCT06344091","phase":"PHASE4","title":"A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-05-21","conditions":"Local Analgesia Via Infiltration","enrollment":232},{"nctId":"NCT04209504","phase":"","title":"Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block","status":"RECRUITING","sponsor":"Duke University","startDate":"2021-10-12","conditions":"Shoulder Surgery, Shoulder Pain, Shoulder Injuries","enrollment":60},{"nctId":"NCT05177991","phase":"EARLY_PHASE1","title":"Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leslie Son","startDate":"2022-03-01","conditions":"Inguinal Hernia, Ventral Hernia","enrollment":200},{"nctId":"NCT05171179","phase":"PHASE3","title":"The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2021-10-22","conditions":"Mammaplasty","enrollment":60},{"nctId":"NCT05285566","phase":"PHASE4","title":"Pain Control for Undergoing Costal Cartilage Harvesting","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-05-04","conditions":"Nasal Surgery","enrollment":60},{"nctId":"NCT02128646","phase":"PHASE4","title":"Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2014-04","conditions":"Pain","enrollment":19},{"nctId":"NCT06946368","phase":"NA","title":"Effectiveness of Exparel Anesthetic Administered by the Surgeon During Knee Surgery","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-08-18","conditions":"Total Knee Arthroplasty","enrollment":60},{"nctId":"NCT05862792","phase":"","title":"Liposomal Bupivacaine and Transoral Robotic Surgery","status":"RECRUITING","sponsor":"Geisinger Clinic","startDate":"2023-06-01","conditions":"Oropharyngeal Cancer, Dysphagia, Oropharyngeal, Post Operative Pain","enrollment":80},{"nctId":"NCT07153614","phase":"NA","title":"Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy","status":"RECRUITING","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-02-03","conditions":"Perioperative Opioid Sparing Techniques","enrollment":200},{"nctId":"NCT05972018","phase":"PHASE4","title":"Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters","status":"RECRUITING","sponsor":"Hartford Hospital","startDate":"2023-10-18","conditions":"Aortic Aneurysm, Abdominal, Abdominal Aortic Occlusion, Aortoiliac Occlusive Disease","enrollment":14},{"nctId":"NCT05900427","phase":"PHASE4","title":"Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients","status":"RECRUITING","sponsor":"Johnny K. Lee","startDate":"2023-09-08","conditions":"Total Shoulder Arthroplasty, Reverse Total Shoulder Arthroplasty","enrollment":120},{"nctId":"NCT06547255","phase":"PHASE4","title":"Exparel Versus Bupivacaine in Post-operative Pain Control","status":"COMPLETED","sponsor":"Case Western Reserve University","startDate":"2024-08-21","conditions":"Liposomal Bupivacaine","enrollment":82},{"nctId":"NCT06231355","phase":"PHASE4","title":"Liposomal vs. Conventional Bupivacaine for Pain Control","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2024-02-21","conditions":"Local Anesthetics, Analgesia, Regional Block","enrollment":61},{"nctId":"NCT07081373","phase":"NA","title":"Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-07-16","conditions":"Anal Fistula","enrollment":408},{"nctId":"NCT07066111","phase":"PHASE4","title":"The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-07-20","conditions":"Postoperative Delirium","enrollment":40},{"nctId":"NCT07049094","phase":"PHASE4","title":"The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2025-06-25","conditions":"Brain Tumor Adult, Cerebrovascular Disease","enrollment":218},{"nctId":"NCT05992896","phase":"PHASE4","title":"A Study of Loco-Regional Liposomal Bupivacaine Injection","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2023-09-26","conditions":"Peripheral Arterial Disease","enrollment":2},{"nctId":"NCT05157841","phase":"PHASE3","title":"Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2022-02-15","conditions":"Bunionectomy, Hallux Valgus","enrollment":185},{"nctId":"NCT04559347","phase":"PHASE2","title":"Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery","status":"TERMINATED","sponsor":"Poovendran Saththasivam","startDate":"2020-12-10","conditions":"Thoracic Surgery","enrollment":45},{"nctId":"NCT05537883","phase":"PHASE1","title":"Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2022-11-29","conditions":"Morbid Obesity, Bariatric Surgery Candidate","enrollment":72},{"nctId":"NCT03731221","phase":"EARLY_PHASE1","title":"Pectoral Fascial Plane and Serratus Anterior Plane Blocks With Bupivacaine v. Liposomal Bupivacaine","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2018-11-01","conditions":"Video Assisted Thoracic Surgery","enrollment":196},{"nctId":"NCT03737292","phase":"PHASE4","title":"Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-04-09","conditions":"Pain, Postoperative, Pharmacokinetics","enrollment":40},{"nctId":"NCT04864210","phase":"PHASE2","title":"Video-assisted Thoracoscopic Surgery - Exparel Study","status":"COMPLETED","sponsor":"Nada Sadek","startDate":"2021-02-02","conditions":"Pain, Postoperative","enrollment":176},{"nctId":"NCT06972680","phase":"","title":"Determination of the Optimal Volume of 0.5% Bupivacaine Liposome in Single-Injection Interscalene Brachial Plexus Block: A Bayesian Phase I/II Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Affiliated Hospital of Jiaxing University","startDate":"2025-05-01","conditions":"Shoulder Arthroscopy","enrollment":60},{"nctId":"NCT05279092","phase":"PHASE2","title":"Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-09-08","conditions":"Total Knee Replacement, Knee Arthroplasty","enrollment":250},{"nctId":"NCT05736549","phase":"PHASE2","title":"Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-02-07","conditions":"Total Knee Replacement, Knee Arthroplasty","enrollment":66},{"nctId":"NCT06962150","phase":"NA","title":"TAP vs QL Block for DIEP Flap Breast Reconstruction","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2023-12","conditions":"Deep Inferior Epigastric Perforator Flap Breast Reconstruction","enrollment":""},{"nctId":"NCT05763667","phase":"PHASE3","title":"Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2024-01-01","conditions":"Post Operative Pain, Gynecologic Cancer","enrollment":15},{"nctId":"NCT04117074","phase":"PHASE3","title":"Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2021-04-14","conditions":"Surgery, Analgesia","enrollment":106},{"nctId":"NCT06810375","phase":"PHASE3","title":"Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery","status":"RECRUITING","sponsor":"George Washington University","startDate":"2025-03-01","conditions":"Lung Cancers","enrollment":120},{"nctId":"NCT04504812","phase":"PHASE3","title":"A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-02-01","conditions":"Knee Osteoarthritis","enrollment":1937},{"nctId":"NCT03854344","phase":"PHASE4","title":"Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2019-03-18","conditions":"Pain, Postoperative, Burns","enrollment":75},{"nctId":"NCT05355597","phase":"PHASE2","title":"\"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors\"","status":"TERMINATED","sponsor":"Atlantic Health System","startDate":"2021-01-27","conditions":"Musculoskeletal Diseases, Soft Tissue Mass","enrollment":116},{"nctId":"NCT05224089","phase":"PHASE4","title":"Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy","status":"RECRUITING","sponsor":"Hartford Hospital","startDate":"2022-04-27","conditions":"Bowel Disease","enrollment":114},{"nctId":"NCT03290196","phase":"PHASE4","title":"The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics","status":"TERMINATED","sponsor":"Andrews Research & Education Foundation","startDate":"2015-09-03","conditions":"Rotator Cuff Tear","enrollment":13},{"nctId":"NCT05374499","phase":"PHASE4","title":"Double-Blinded Randomized Controlled Study Investigating the Efficacy of Exparel (Liposomal Bupivacaine) for Postoperative Pain Relief in Mandibular Third Molar Extractions","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2022-09-01","conditions":"Post Operative Pain","enrollment":73},{"nctId":"NCT04680221","phase":"PHASE4","title":"Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Missouri, Kansas City","startDate":"2021-03-01","conditions":"Pain, Postoperative, Opioid Use","enrollment":97},{"nctId":"NCT04393207","phase":"PHASE4","title":"TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery","status":"TERMINATED","sponsor":"Yale University","startDate":"2022-02-01","conditions":"Opioid Use, Pain, Acute","enrollment":147},{"nctId":"NCT05068960","phase":"PHASE4","title":"Postoperative Pain Control in Total Shoulder Arthroplasty","status":"COMPLETED","sponsor":"Scripps Clinic","startDate":"2021-03-01","conditions":"Total Shoulder Arthroplasty","enrollment":100},{"nctId":"NCT06349772","phase":"EARLY_PHASE1","title":"Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy","status":"RECRUITING","sponsor":"Texas Tech University Health Sciences Center","startDate":"2024-11-01","conditions":"Post Operative Pain","enrollment":130},{"nctId":"NCT05823363","phase":"PHASE4","title":"Vaginal Cuff Infiltration With Liposomal Bupivacaine for Pain Relief: A Double Blind, Randomized Controlled Trial","status":"COMPLETED","sponsor":"Maimonides Medical Center","startDate":"2024-09-09","conditions":"Postoperative Pain","enrollment":15},{"nctId":"NCT05964868","phase":"PHASE3","title":"Efficacy of Liposomal Bupivacaine Post Septorhinoplasty","status":"ENROLLING_BY_INVITATION","sponsor":"Jessyka Lighthall","startDate":"2024-02-05","conditions":"Rhinoplasty, Pain Management","enrollment":72},{"nctId":"NCT06077214","phase":"PHASE1","title":"Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2023-01-31","conditions":"Bariatric Surgery Candidate, Post-operative Pain","enrollment":9},{"nctId":"NCT03859635","phase":"PHASE3","title":"Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures","status":"COMPLETED","sponsor":"Indiana University","startDate":"2019-02-07","conditions":"Pain, Postoperative, Thoracic, Acute Pain","enrollment":120},{"nctId":"NCT06350981","phase":"PHASE2, PHASE3","title":"Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion","status":"ENROLLING_BY_INVITATION","sponsor":"Foundation for Orthopaedic Research and Education","startDate":"2024-04-30","conditions":"Back Pain, Surgery-Complications, Narcotic Use","enrollment":76},{"nctId":"NCT04300231","phase":"PHASE3","title":"Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy","status":"COMPLETED","sponsor":"Indiana University","startDate":"2019-10-22","conditions":"Cystectomy","enrollment":160},{"nctId":"NCT06806410","phase":"PHASE4","title":"The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Luke's Hospital, Pennsylvania","startDate":"2023-05-01","conditions":"Hand Surgery, Wrist Surgery, Elbow Surgery","enrollment":120},{"nctId":"NCT05664958","phase":"PHASE4","title":"ESP Block for Post Cesarean Analgesia","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-04-17","conditions":"Cesarean Section Complications","enrollment":150},{"nctId":"NCT06603051","phase":"NA","title":"The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction","status":"RECRUITING","sponsor":"Virtua Health, Inc.","startDate":"2024-08-28","conditions":"ACL Repair","enrollment":20},{"nctId":"NCT04603911","phase":"PHASE2","title":"RCT Comparing ESPB Solutions in Breast Surgery","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2020-12-04","conditions":"Breast Cancer","enrollment":75},{"nctId":"NCT06135545","phase":"NA","title":"Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block","status":"WITHDRAWN","sponsor":"Shiyou Wei","startDate":"2023-10-01","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT03094663","phase":"PHASE4","title":"Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-02-28","conditions":"Knee Arthropathy","enrollment":86},{"nctId":"NCT03745040","phase":"PHASE4","title":"Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion","status":"SUSPENDED","sponsor":"Allina Health System","startDate":"2019-01-26","conditions":"Lumbar Spinal Stenosis, Lumbar Disc Herniation, Lumbar Disc Disease","enrollment":60},{"nctId":"NCT04364867","phase":"PHASE4","title":"Exparel for Total Shoulder Arthroplasty","status":"COMPLETED","sponsor":"Norton Healthcare","startDate":"2020-08-12","conditions":"Total Shoulder Arthroplasty","enrollment":102},{"nctId":"NCT06252662","phase":"PHASE4","title":"Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies","status":"RECRUITING","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2024-10-15","conditions":"Breast Cancer","enrollment":200},{"nctId":"NCT06452147","phase":"NA","title":"Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2024-06-19","conditions":"Anesthesia, Hip Fractures, Dementia","enrollment":1860},{"nctId":"NCT06646172","phase":"NA","title":"Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-10-24","conditions":"Median Sternotomy","enrollment":38},{"nctId":"NCT05139030","phase":"PHASE3","title":"Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2022-01-18","conditions":"Knee Osteoarthritis, Pain Management","enrollment":167},{"nctId":"NCT06653621","phase":"PHASE4","title":"Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement","status":"NOT_YET_RECRUITING","sponsor":"Huazhong University of Science and Technology","startDate":"2024-11-05","conditions":"Knee Arthropathy, Knee Arthritis","enrollment":144}],"_emaApprovals":[],"_faersSignals":[{"count":245,"reaction":"OFF LABEL USE"},{"count":236,"reaction":"LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR"},{"count":193,"reaction":"NO ADVERSE EVENT"},{"count":178,"reaction":"DRUG INEFFECTIVE"},{"count":134,"reaction":"HYPOAESTHESIA"},{"count":134,"reaction":"PAIN"},{"count":120,"reaction":"HOSPITALISATION"},{"count":72,"reaction":"PROCEDURAL PAIN"},{"count":63,"reaction":"EXTRA DOSE ADMINISTERED"},{"count":57,"reaction":"HYPOTENSION"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL1098"},"formularyStatus":[],"_approvalHistory":[{"date":"20231109","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20140813","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20210106","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20140328","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20130710","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20160415","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20151008","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20181102","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20150727","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20160610","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20150527","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20141215","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20111028","type":"ORIG","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20180406","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20210402","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20231128","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20140605","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20210322","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20141205","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20151214","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20160405","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20170308","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"},{"date":"20150911","type":"SUPPL","sponsor":"PACIRA PHARMS INC","applicationNumber":"NDA022496"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":166,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Exparel","genericName":"Exparel","companyName":"University of Tennessee","companyId":"university-of-tennessee","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":55,"withResults":28},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:15:10.379889+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}